MentionFox
Home › funding signals › Chronicle Bio, Inc.
Form D · on the record

Chronicle Bio — $250K Form D filing, November 2026

Before you sell to, join or invest in Chronicle Bio, Inc.

MentionFox check on Chronicle Bio, Inc.: only 1 source on file so far (checked 14 November 2026). Run a full check before you rely on it. mentionfox.com/c/funding/chronicle-bio-inc-form-d-000003

Check Chronicle Bio, Inc. before you sell to, join or invest Free, no sign-up: every record on file, each linked to its source.

What do you want to do about Chronicle Bio, Inc.?

Chronicle Bio, Inc. filed a Form D with the Securities and Exchange Commission on 2026-11-12.

Chronicle Bio, Inc. filed a Form D notice of an exempt securities offering with the SEC on November 12, 2026. The filing reports $250K sold. Its industry group is Other Technology. It names Rohit Gupta (Executive Officer, Director), Rishi Reddy (Executive Officer, Director), Jay Santoro (Director) (SEC Form D, November 12, 2026).

Sell to companies like Chronicle Bio, Inc? Enter your website and see 10 with a filed reason to buy from you this month. Free.

Opens in a new tab. No signup.

Chronicle Bio, Inc. raised on Nov 12. 88 companies raised this week, 1 had other signals.

Companies that just raised money, and the people to call. Before you unlock: the company, the amount, the date and what is inside (for example 2 people, phone, LinkedIn). After: the officers and directors the filing names with their roles, how to reach the company, and a person's email only when we found one.

fal - Features & Labels, Inc.$1BAI and software
fal - Features & Labels, Inc.$350MAI and software
SIERRA INTERNATIONAL NETWORK INC$300MAI and software
Zai Lab Ltd$250MBiotech
Databento Inc.$100MAI and software
Check one company free All companies that raised this week

1 more Other Technology raise in California, November 2026 ↓

Selling to Chronicle Bio, Inc.? See who runs it and how to reach them, plus this week's 84 other newly funded companies.

Is this your company?

Key facts

Run the free check on Chronicle Bio, Inc. →

Chronicle Bio, Inc.

New Form D on file · 2026-11-12 · the record

$250K
raise on the record
D
filing
1
investors in
CALIFORNIA
based
Open the record →

What the record says

FilingForm D
Filed2026-11-12
Industry groupOther Technology
Entity typeCorporation
Incorporated inDELAWARE
Year formed2025
BasedMenlo Park, CALIFORNIA
CIK2090889
Accession0002090889-26-000003

Pitching, partnering or investing alongside them? See who really runs and owns Chronicle Bio, Inc.

Free to see. No signup.

Keep reading

More on the people and the money behind Chronicle Bio, Inc., from the filings we hold.

More raises like this

Other Technology raises by companies based in California, filed in November 2026, largest first.

What do you want to do with Chronicle Bio, Inc.?

Get the full cited report on Chronicle Bio, Inc.

What the filing shows about Chronicle Bio, Inc.

  • 1 investor had already put money in when it filed.
  • The filing names 4 people as officers, directors or promoters.

Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.

Example from a real report (our sample on Target): “In March 2026, Target announced a planned incremental $1 billion operating investment” Source: Target Corporation (press release)

A Full Report on Chronicle Bio, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.

See a sample report

Just raised? Your investors will ask for updates.

The weeks after a raise are when investors, other founders and press look Chronicle Bio, Inc. up. FoxPlug is your startup's chief of staff: it reads your whole stack and tells you what to fix, what to say and what to skip, for founders shipping with Claude Code, Codex or Cursor. It drafts your monthly investor update from your real numbers, and its free tools need no account. GetFoxChat puts an AI operator on Chronicle Bio, Inc.'s own site, named as you like, so the visitors this record sends you don't read one page and leave.

Who the filing names, and in what role

The filing gives Chronicle Bio, Inc.'s address as 1080 O'Brien Drive, Suite B, Menlo Park, CA 94025.

What the filing says

  • Offered: $1,000,000. Sold: $250,000. Left to sell: $750,000. (filing)
  • Investors: 1 had already invested. (filing)
  • Date of first sale: October 28, 2026. (filing)
  • Types of securities: Options, warrants or other rights to acquire another security. (filing)
  • Item 16: the filing reports that none of the proceeds goes to executive officers, directors or promoters. (filing)

This is the company's own disclosure. A payment disclosed on a Form D is a disclosed use of proceeds, not a finding of wrongdoing.

Order the Full Report on Chronicle Bio, Inc. See pricing

Is Chronicle Bio, Inc. a real, registered company?

Chronicle Bio, Inc. is a registered filer with the SEC (CIK 2090889) and has filed since 2025-10-15. 6 filings are on record, the latest on 2026-11-12.

A filing shows the company exists and what it reports about itself. It is not an audit or a rating.

Who runs Chronicle Bio, Inc.?

Chronicle Bio, Inc.'s Form D of 2026-11-12 names Rohit Gupta, Rishi Reddy, Jay Santoro and 1 more as its officers, directors or promoters.

How much has Chronicle Bio, Inc. raised?

Its new offerings report $2.48M sold across 2 offerings, as its own filings state.

Filing history · 6 filings on this registrant
Form D · 2025-10-15 · $2.23MForm D/A, amended · 2025-11-17 · $3.18MForm D/A, amended · 2026-01-07 · $5.36MForm D/A, amended · 2026-07-07 · $10.27MForm D/A, amended · 2026-11-12 · $15.37MForm D · 2026-11-12 · $250K · this page 2025-10-15 2026-11-12

A hollow marker is an amendment (Form D/A); a solid one is an original Form D. The larger marker is the filing this page is about.

Other Technology · by week
This raise, $250K, filed week of Nov 9

Trailing twelve months. 3883 filings in Other Technology, totalled by week. The dot is this raise, $250K, on the same scale — one filing against the whole group's total, so it sits low by construction.

Want the whole picture on Chronicle Bio, Inc.?

What the filing shows about Chronicle Bio, Inc.

  • 1 investor had already put money in when it filed.
  • The filing names 4 people as officers, directors or promoters.

Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.

Example from a real report (our sample on Target): “In March 2026, Target announced a planned incremental $1 billion operating investment” Source: Target Corporation (press release)

A Full Report on Chronicle Bio, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.

What the Full Report on Chronicle Bio, Inc. covers

  1. The Short Answer

  2. Which Company This Is

  3. What They Do, And How The Money Works

  4. Who Runs It, And How To Reach Them

  5. The Money: Funding, Valuation, Runway

  6. Who Pays Them, And Who They Are Up Against

  7. Warning Bells

  8. Sources

    1 cited source found

Plus the sections for what you are deciding, which you pick after ordering.

See a sample report

First screen of a real sample Full Report on EchoStar: the verdict, 17 sections, 63 cited sources, built 2026-10-21A real finished report, first screen. Opens in a new tab.

The full profile

Checking your access…

Sourced from the filing index on sec.gov.

Follow this companyRSS

Tools for this story

Each opens in a new tab, filled in for Chronicle Bio, Inc.. With no account yet, you sign up free and land on the result.

Share this page

Is this your company?

Share your raise. This card is drawn from the company's own Form D filing, and sharing needs no account.

Chronicle Bio, Inc.: Raised $250K, Form D filed 2026-11-12
Share on LinkedIn Share on X Download image

Cite this page

Permanent URL: https://mentionfox.com/funding/chronicle-bio-inc-form-d-000003
Last updated 2026-11-14
Primary record: SEC filing 1 · SEC filing 2
Chronicle Bio raised $250K — SEC Form D filing, November 2026. MentionFox, 2026-11-14. https://mentionfox.com/funding/chronicle-bio-inc-form-d-000003